In our previous study, we demonstrated that IRF9 inhibits the development of cardiac hypertrophy, and we determined that IRF9 directly interacts with myocardin to suppress its activity and the transcription of SRF (serum response factor) downstream genes in cardiomyocytes19. This evidence concerns the gene MYOCD and cardiac hypertrophy.